Tenax Therapeutics, Inc. · NASDAQ:TENX

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Tenax Therapeutics, Inc., 3,110,363 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
3,110,363
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P9.50%2,966,661
BVF I GP LLC9.50%2,966,661
BIOTECHNOLOGY VALUE FUND II LP0.50%141,570
BVF II GP LLC0.50%141,570
Biotechnology Value Trading Fund OS LP0%7
BVF Partners OS Ltd.0%7
BVF GP HOLDINGS LLC9.98%3,108,231
BVF PARTNERS L P/IL9.99%3,110,363
BVF INC/IL9.99%3,110,363
LAMPERT MARK N9.99%3,110,363

Source

View original at SEC

Related